Synthon’s Anti-HER2 ADC Frontrunner SYD985 Outperforms HER2-targeting ADC

News   Apr 03, 2014

 
Synthon’s Anti-HER2 ADC Frontrunner SYD985 Outperforms HER2-targeting ADC
 
 
FURTHER INFORMATION
 
 
 
 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE